This article first appeared on GuruFocus .
-
Pro Forma Underlying EBITDA:Increased by 20% to $97.7 million.
-
Sales Volumes:Up 16% to the highest level since FY22.
-
Free Cash Flow from Operations:Improved from an outflow of $41.7 million in FY25 to an outflow of $15 million in FY26.
-
Net Debt:Reduced by more than $121 million to $506.7 million.
-
Gearing:Reduced to 30.1%, at the lower end of the target range.
-
Development Margin:29.9%.
-
Resale Margin:17.5%.
-
Care EBITDA per Bed:Increased by 40% to around $27,000.
-
Occupancy Rate:95.5% on a rolling 12-month basis.
-
Structural Cost Savings:$13.2 million achieved, with a target of $30 million in combined cost and cash improvements.
-
Operating Free Cash Flow:Outflow reduced by 64% to $15 million from $42 million in FY25.
-
Divestments:Seven divestments generating approximately $51 million of proceeds.
-
Underlying NPAT:$59.4 million, up from $42.3 million in the prior comparable period (PCP).
-
Net Tangible Assets:$1.2 billion.
-
Warning! GuruFocus has detected 6 Warning Signs with ASX:OCA.
-
Is ASX:OCA fairly valued? Test your thesis with our free DCF calculator.
Release Date: May 21, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Oceania Healthcare Ltd ( ASX:OCA ) reported a record underlying EBITDA increase of 20% to $97.7 million, driven by operational improvements and record sales volumes.
-
The company significantly reduced net debt by over $121 million, bringing it down to $506.7 million, and reduced gearing to 30.1%, which is at the lower end of their target range.
-
Sales performance was strong, with a 16% increase in sales volumes, the highest since FY22, and a 9% improvement in average pricing.
-
Oceania achieved substantial progress in repositioning for growth, establishing a platform for stronger earnings growth and cash generation.
-
The company successfully completed a divestment program, generating approximately $51 million from seven divestments, which improved portfolio quality and supported debt reduction.
Negative Points
-
The directors resolved not to declare a final dividend, with a focus on generating positive free cash flow from operations in FY27.
-
Free cash flow from operations, although improved, still resulted in an outflow of $15 million, down from $41.7 million in FY25.
-
The company faces challenges in the residential property market, with many prospective residents finding it harder to sell their existing homes.
-
Oceania is experiencing construction cost inflation, with potential impacts on margins if inflation exceeds current contingency plans.
-
There is a need for continued focus on reducing development stock and maintaining debt at the lower end of the target range.
Q & A Highlights
Q: Can you provide details on the CBRE embedded value of resale gains at FY26, especially with the repricing of some stock? A: Kathryn Waugh, CFO: We haven't included that slide this year, but we can provide the specifics in a one-on-one later today. The repricing was targeted at specific units, not across the portfolio, and overall, we've seen an uptick in sales prices.
Q: What is the rationale for prioritizing Green Bay Stage 2, and can you update on the timing for delivering villas at Gracelands? A: Kathryn Waugh, CFO: Green Bay Stage 2 completes the existing site and meets demand. We have design ready and existing consent. For Gracelands, we are refining the design now, aiming for delivery in 2028.
Q: Are there plans to develop more apartments at Elmwood in 2028 or 2029? A: Kathryn Waugh, CFO: The focus is on conversions for now. We have consent for more apartments, but they are not planned for 2028.
Q: How does Oceania plan to address the NTA gap, and is a strategic review being considered? A: Suzanne Dvorak, CEO: We recognize the discount and potential accretion at the current share price, but our priority is cash generation and balance sheet discipline. We will continue to review but have no update at this stage.
Q: With construction cost inflation at 10% to 15%, how will Oceania protect margins? A: Suzanne Dvorak, CEO: For Franklin Stage 2, we have contingencies in place to adapt to this level of inflation. If costs rise further, we will reconsider our approach.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
